Our mission is to make a meaningful difference to healthcare through great medicines. This is founded on the pursuit of scientific excellence that addresses unmet patient need.
Our expertise spans the entire life-cycle of a medicine and we have capabilities in both small molecules and biologics. This allows us to search for solutions to unmet medical needs using both modalities, individually or in combination.
Petrov Institute: Working together to lead personalised cancer research in Russia
IMED collaboration case studies
This video features the N.N. Petrov Institute for Oncology, one of Russia’s leading cancer research institutions. Together, we are working to identify innovative new approaches to treating cancer.Download case study (PDF 242kb)
AstraZeneca’s Innovative Medicines & Early Development (IMED) Biotech Unit collaborates with hundreds of academic institutions and biotechs across the globe, in an effort to bring novel medicines to patients faster. Our scientists collaborate across geographic borders, accessing and adding to the best ideas, wherever they may be. Our collaboration partners tell us they enjoy working with AstraZeneca. But don’t take our word for it. Hear it from them.
All Directors are collectively responsible for the success of AstraZeneca. Discover general information, images and biographies of our Board of Directors.
AstraZeneca's pipeline is one of the most exciting in the industry. Download the latest version of our development pipeline.
Path to new medicines
The discovery, development and commercialisation of a medicine is a complex process. Information on our path to new medicines and an interactive overview are available.
Visit our dedicated neuroscience site for more information on our research and partnering in the area.
Visit our Open Innovation site to see how we collaborate to push the boundaries of science and deliver life-changing medicines